2 weeks Ago By ABMN Staff
Xponance Inc. raised its stake in shares of Dolby Laboratories, Inc. ( NYSE:DLB – Free Report ) by 6.
4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,690 shares of the electronics maker’s stock after purchasing an additional 525 shares during the quarter. Xponance Inc.
’s holdings in Dolby Laboratories were worth $679,000 as of its most recent filing with the Securities and Exchange Commission. Several other large investors also recently modified their holdings of the stock. Victory Capital Management Inc.
boosted its stake in Dolby Laboratories by 18.5% in the 3rd quarter. Victory Capital Management Inc.
now owns 14,665 shares of the electronics maker’s stock valued at $1,122,000 after buying an additional 2,288 shares in the last quarter. Advisors Asset Management Inc. lifted its holdings in shares of Dolby Laboratories by 26.
8% during the third quarter. Advisors Asset Management Inc. now owns 3,560 shares of the electronics maker’s stock valued at $272,000 after acquiring an additional 753 shares during the period.
Citigroup Inc. boosted its stake in shares of Dolby Laboratories by 3.9% in the 3rd quarter.
Citigroup Inc. now owns 72,727 shares of the electronics maker’s stock valued at $5,566,000 after purchasing an additional 2,724 shares in the last quarter. Algert Global LLC grew its holdings in shares of Dolby Laboratories by 52.
0% in the 3rd quarter. Algert Global LLC now owns 48,822 shares of the electronics maker’s stock worth $3,736,000 after purchasing an additional 16,700 shares during the last quarter. Finally, Bank of Montreal Can increased its position in shares of Dolby Laboratories by 27.
8% during the 3rd quarter. Bank of Montreal Can now owns 39,350 shares of the electronics maker’s stock worth $2,975,000 after purchasing an additional 8,562 shares in the last quarter. 58.
56% of the stock is currently owned by institutional investors. Wall Street Analysts Forecast Growth Several analysts have recently weighed in on the stock. Rosenblatt Securities reaffirmed a “buy” rating and set a $100.
00 price objective on shares of Dolby Laboratories in a report on Thursday, January 30th. StockNews.com downgraded Dolby Laboratories from a “strong-buy” rating to a “buy” rating in a research report on Friday, January 31st.
Finally, Barrington Research restated an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research note on Thursday, February 13th. Dolby Laboratories Stock Down 0.
1 % Shares of DLB stock opened at $81.56 on Wednesday. The firm has a market cap of $7.
78 billion, a price-to-earnings ratio of 29.99 and a beta of 1.01.
Dolby Laboratories, Inc. has a 12 month low of $66.35 and a 12 month high of $89.
66. The stock has a 50-day moving average price of $82.26 and a 200 day moving average price of $78.
07. Dolby Laboratories Dividend Announcement The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 19th. Investors of record on Tuesday, February 11th were paid a dividend of $0.
33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.
62%. The ex-dividend date of this dividend was Tuesday, February 11th. Dolby Laboratories’s dividend payout ratio (DPR) is 48.
53%. Insider Activity at Dolby Laboratories In other news, CAO Ryan Nicholson sold 7,000 shares of the stock in a transaction on Wednesday, February 5th. The stock was sold at an average price of $84.
07, for a total value of $588,490.00. Following the transaction, the chief accounting officer now owns 29,758 shares of the company’s stock, valued at $2,501,755.
06. This represents a 19.04 % decrease in their position.
The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink . Also, CMO Todd Pendleton sold 18,121 shares of the firm’s stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $83.
75, for a total value of $1,517,633.75. Following the completion of the transaction, the chief marketing officer now owns 37,290 shares in the company, valued at $3,123,037.
50. This represents a 32.70 % decrease in their ownership of the stock.
The disclosure for this sale can be found here . Insiders have sold 65,121 shares of company stock worth $5,501,324 over the last ninety days. Company insiders own 38.
39% of the company’s stock. Dolby Laboratories Company Profile ( Free Report ) Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Recommended Stories Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter ..
